X0306 4 2021-05-18 0 0001831828 Vera Therapeutics, Inc. VERA 0001720685 Katabi Maha C/O VERA THERAPEUTICS, INC. 170 HARBOR WAY, 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 1 0 1 0 Class A Common Stock 2021-05-18 4 C 0 2187504 A 2187504 I See footnote Class A Common Stock 2021-05-18 4 P 0 727272 11.00 A 2914776 I See footnote Series C Preferred Stock 2021-05-18 4 C 0 2187504 0.00 D Class A Common Stock 2187504 0 I See footnote The Series C Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date. The shares are held directly by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.L.C. ("SM X") is the general partner of SVP X and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by SVP X. James I. Healy, Maha Katabi, and Michael F. Powell are the managing members of SM X and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by SVP X. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of her proportionate pecuniary interest therein. /s/ Joseph R. Young, Attorney-in-Fact 2021-05-18